AI-driven protein design is outpacing its manufacturing backbone—and the sector’s next wave will belong to those who control the biofoundry.
Coinbase’s AI Code Shift: The Silent Moat in Crypto’s Talent War
Neuralink’s Moat Just Narrowed: China’s First Commercial BCI Implant Lands
3D Systems Loses Regenerative Medicine Pioneer as Weimer Exits After 17 Years